PP003

PP003 is a generic solution for inhalation being developed by Plano Pharmaceuticals for the treatment of respiratory diseases. As part of Plano's product development pipeline, which focuses on addressing drug shortages in North America through the production of sterile injectables and inhalation products, PP003 is currently in the ongoing development stage. While the specific active pharmaceutical ingredient and molecular targets have not been publicly disclosed, the drug is formulated as a solution intended for administration via inhalation. Plano Pharmaceuticals aims to provide high-quality generic alternatives to essential medications within the respiratory therapeutic area.